Pulmonary vasomodulators in adults with repaired pulmonary atresia with ventricular septal defect: Single-center experience and review of literature
This study suggests relative safety and potential benefit of pulmonary vasomodulator therapies in adults with PH and PA-VSD.
Authors
- Hilary M. DuBrock (ORCID: https://orcid.org/0000-0001-8410-4429)
- C. Charles Jain (ORCID: https://orcid.org/0000-0002-1116-8541)
- Kirsten Lipps (ORCID: https://orcid.org/0000-0001-8298-4776)
- Alexander C. Egbe (ORCID: https://orcid.org/0000-0002-8810-3631)
- Robert P. Frantz (ORCID: https://orcid.org/0000-0003-4128-3978)
- Heidi M. Connolly (ORCID: https://orcid.org/0000-0003-0666-0344)
- William R Miranda
Institutions
- Northwestern University (US)
- Mayo Clinic (US)
- Mayo Clinic in Arizona (US)
Publication Details
- Journal
- International Journal of Cardiology Congenital Heart Disease
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1016/j.ijcchd.2025.100643
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00